Holen Sie sich die Stockscreener-App
5.51
0.18%
0.010
Handel nachbörslich:
5.51
Schlusskurs vom Vortag:
$5.50
Offen:
$5.5
24-Stunden-Volumen:
141.17K
Relative Volume:
1.03
Marktkapitalisierung:
$197.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.61%
1M Leistung:
+14.79%
6M Leistung:
+47.33%
1J Leistung:
-77.16%
1-Tages-Spanne:
$5.32
$5.60
1-Wochen-Bereich:
$5.245
$5.76
52-Wochen-Spanne:
$2.88
$26.62
Bioage Labs Inc Stock (BIOA) Company Profile
Firmenname
Bioage Labs Inc
Sektor
Telefon
510-806-1445
Adresse
5885 HOLLIS STREET, EMERYVILLE
Vergleichen Sie BIOA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIOA
Bioage Labs Inc
|
5.51 | 197.18M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
143.46 | 63.05B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.80 | 43.33B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.17 | 40.43B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.11 | 22.97B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
433.61 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-28 | Eingeleitet | William Blair | Mkt Perform |
| 2024-12-10 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2024-12-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-09 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-21 | Eingeleitet | Citigroup | Buy |
| 2024-10-21 | Eingeleitet | Jefferies | Buy |
| 2024-10-21 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Bioage Labs Inc Aktie (BIOA) Neueste Nachrichten
Analyzing drawdowns of BioAge Labs Inc. with statistical toolsQuarterly Profit Summary & Verified Momentum Stock Alerts - newser.com
What drives BioAge Labs Inc Y7G stock priceStock Buyback Updates & Amplify Gains With Picks - earlytimes.in
Short interest data insights for BioAge Labs Inc.2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com
BioAge Labs (NASDAQ:BIOA) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
Can BioAge Labs Inc. stock sustain revenue growthPortfolio Return Summary & Real-Time Volume Analysis Alerts - newser.com
Can trapped investors hope for a rebound in BioAge Labs Inc.2025 Analyst Calls & Growth Focused Entry Reports - newser.com
What drives BioAge Labs Inc stock priceEarnings Surprise Analysis & Minimal Investment Trading - earlytimes.in
Developing predictive dashboards with BioAge Labs Inc. data2025 Key Lessons & Weekly Top Gainers Trade List - newser.com
Can momentum traders help lift BioAge Labs Inc.M&A Rumor & Weekly High Conviction Ideas - newser.com
Using Ichimoku Cloud for BioAge Labs Inc. technicals2025 Top Gainers & Low Risk Entry Point Guides - newser.com
Will BioAge Labs Inc. stock outperform tech sector in 20252025 Geopolitical Influence & Capital Protection Trading Alerts - newser.com
How strong is BioAge Labs Inc. (Y7G) stock earnings growth2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com
Analyzing net buyer seller activity in BioAge Labs Inc.Market Rally & Low Drawdown Investment Ideas - newser.com
BIOAGE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
How high can BioAge Labs Inc. stock go2025 Buyback Activity & Precise Buy Zone Tips - newser.com
BioAge Labs files for mixed shelf offering of up to $250 millionSEC filing - MarketScreener
BioAge Labs Files $250 Million Mixed Shelf - MarketScreener
Is BioAge Labs Inc a good long term investmentStock Valuation Metrics & Your Free Entry to Smart Investing Starts Here - earlytimes.in
What analysts say about BioAge Labs Inc Y7G stockMarket Capitalization Trends & Reap the Rewards of Patience + Planning - earlytimes.in
BioAge Labs Inc Y7G Stock Analysis and ForecastFibonacci Extensions & Build Winning Portfolio - earlytimes.in
BioAge Labs, Inc. (NASDAQ:BIOA) institutional owners may be pleased with recent gains after 74% loss over the past year - simplywall.st
Finanzdaten der Bioage Labs Inc-Aktie (BIOA)
Es liegen keine Finanzdaten für Bioage Labs Inc (BIOA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
2.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):